European Health Data Space (EHDS): Regulation, Implementation and Impact on Healthcare

Kate Williamson, Editorial Team, European Hospital & Healthcare Management

The European Health Data Space (EHDS) is the EU’s first sector-specific data framework, built to give patients control over their health records and open a regulated path for research. This article explains the regulation, the 2027-2031 implementation timeline, primary and secondary data use, and the expected impact on healthcare delivery.

EHDS

Introduction:

Quick answer: The European Health Data Space is an EU regulation, Regulation (EU) 2025/327, that lets patients access their electronic health records anywhere in Europe. It also creates a controlled route for researchers and policymakers to reuse health data. It entered into force in March 2025 and applies in stages from 2027 to 2035.

If you’ve ever tried to explain your medical history to a doctor in another country, you already know the problem the EHDS is trying to fix. Your records exist, but they sit in separate systems that don’t talk to each other. This guide covers what the regulation says, how implementation is going and what it means for healthcare in practice.

What is the European Health Data Space?

The European Health Data Space is the first common EU data space built for a single sector. It is a core piece of the European Health Union. It sets shared rules, standards and infrastructure so electronic health data can move safely across borders, and it sits on top of the GDPR rather than replacing it.

It has two goals:

1.    Give people control over their own health data and make it usable across the EU.
2.    Make health data available, under strict conditions, for research, innovation and public policy.

These goals are known as primary use and secondary use, and they are the backbone of the whole regulation.

Part 1: The EHDS regulation explained

The European Commission proposed the EHDS in 2022. After long negotiations it was adopted in early 2025, published in the Official Journal on 5 March 2025, and entered into force on 26 March 2025.

Think of the regulation as four building blocks:

  • Patient rights: free and immediate access to your own electronic health data. You can add information, request corrections, restrict who sees your data and opt out of secondary use.
  • Common standards: a shared European electronic health record exchange format, so a hospital in Lyon and a clinic in Lisbon can read the same record.
  • Software rules: electronic health record (EHR) systems sold in the EU must meet interoperability and logging requirements.
  • Governance: each Member State sets up a digital health authority and a health data access body, coordinated by a European-level board.

Primary and secondary use of health data: what’s the difference?

This is the question people search most, and many articles blur it.

  Primary use Secondary use
Purpose Delivering care to you Research, innovation, policy, statistics
Who benefits Patients and clinicians Researchers, public bodies, industry (within limits)
Data form Identifiable, in your care context Mostly anonymised or pseudonymised
Access route National patient portals, EU cross-border services A permit from a health data access body
Patient control Access, restrict, correct Opt-out right

Primary use means your data supports your own treatment. Cross-border exchange runs through MyHealth@EU, the EU’s existing digital health infrastructure. The first priority categories are patient summaries and ePrescriptions/eDispensations. Medical images, lab results and hospital discharge reports follow later.

Secondary use is the more sensitive half, so the safeguards matter. Researchers can’t simply download datasets. They apply to a national health data access body, state a legitimate purpose and, if approved, work inside a secure processing environment. Cross-border requests run through HealthData@EU. Permitted purposes include public health, scientific research, policymaking and developing medical technologies. Using the data to harm individuals, for example to deny insurance, or for marketing is prohibited.

Part 2: EHDS implementation timeline

The regulation applies gradually. These are the dates that matter:

  • 26 March 2025: The regulation enters into force and the transition period begins.
  • 26 March 2027: General application date, and the deadline for the Commission to adopt the key implementing acts (technical specifications and detailed operating rules).
  • 26 March 2029: Key parts apply, including the new health data rights, primary-use exchange of patient summaries and ePrescriptions, and secondary use for most data categories.
  • 26 March 2031: Exchange of medical images, lab results and discharge reports must be operational. Secondary-use provisions for certain categories, such as genetic data and clinical trial data, also begin.
  • 26 March 2035: A further long-tail provision under Article 75(5) applies.

Where are we now (October 2026)? We are in the heaviest preparation window. The big technical rules are due by March 2027, so standards, certification schemes and national governance bodies are all being shaped right now. Organizations that wait for the final text before preparing will be squeezed.

What Member States and organizations need to do

Governments must designate digital health authorities and health data access bodies, build or upgrade national access services, and connect to MyHealth@EU and HealthData@EU.

Hospitals, labs, pharmacies and other data holders should:

1.    Map their data. Know which datasets you hold and in what format. Data holders will need to describe their datasets to the health data access body regularly.
2.    Check their EHR systems. Software must be able to send and receive priority data categories in the European exchange format.
3.    Review GDPR alignment. The EHDS doesn’t replace GDPR, cybersecurity or medical device rules. It sits on top of them, so compliance is really a mapping exercise across several laws.
4.    Plan for patient access. Patients will expect to see their data quickly and at no cost.

EHR and health-tech vendors face the most pressure. Interoperability and logging requirements, plus conformity assessment, make the EHDS a product-design issue as well as a legal one.

Part 3: EHDS impact on healthcare

Here is the honest picture, with benefits and friction both included.

For patients

  • Better continuity of care when travelling, moving or living near a border.
  • A clearer, single view of their own medical history.
  • More say over who sees their data and whether it is reused for research.

For clinicians

  • Faster access to a patient’s history, especially in emergencies.
  • Fewer repeated tests and less manual record-chasing.
  • Possibly more documentation work in the short term while systems are standardised.

For researchers and life sciences

  • A larger and more consistent pool of data than any single country offers, which is especially valuable for rare diseases.
  • A clear, permit-based route to data, replacing today’s patchwork of national rules.

For health systems and regulators

  • Better data for planning, surveillance and evaluating what treatments work in real life.
  • The friction to plan for
  • Uneven digital maturity between countries means progress won’t be uniform.
  • Smaller providers may struggle with compliance costs.
  • Public trust is the make-or-break factor. If people feel their data is misused, opt-outs will rise and the research value will shrink.

European health data sharing: is my data safe?

The EHDS does not create one giant central database. Data generally stays with the organizations and countries that hold it, and is exchanged through national contact points and EU infrastructure. Secondary use relies on secure environments where researchers analyze data without taking it away, and results are generally released in anonymous or aggregated form.

No system is risk-free. But the design principle is clear: share access, not raw copies, and keep patients informed and in control.

Frequently asked questions

What is the European Health Data Space in one sentence?

It is an EU framework that lets people access and share their electronic health data across borders and allows regulated reuse of that data for research and policy.

Is the EHDS already in force?

Yes. The regulation entered into force on 26 March 2025, but its obligations apply in stages from 2027 to 2031 and beyond.

Does the EHDS replace GDPR?

No. It complements GDPR and other EU laws, adding sector-specific rules for health data.

Can I opt out of having my data used for research?

The regulation gives individuals a right to opt out of secondary use, though details such as exceptions and procedures depend on national implementation.

Who can access health data under secondary use?

Applicants with a legitimate, permitted purpose who receive a data permit from a national health data access body.

Does the EHDS affect companies outside the EU?

Potentially yes. Vendors selling EHR systems in the EU, and organisations that want to use EU health data, will need to understand the requirements.

The bottom line

The European Health Data Space is less a single event than a decade-long rebuild of how Europe handles health information. For patients, it promises records that finally follow them. For researchers, it opens a regulated door to data at scale. For everyone in between, it means standards, governance and compliance work that is better started in 2026 than in 2028.

If you work in healthcare, health-tech or life sciences, start with a simple data inventory and a gap check of your EHR systems. That alone puts you ahead of most.

Kate Williamson

Kate, Editorial Team at European Hospital & Healthcare Management, leverages her extensive background in Healthcare communication to craft insightful and accessible content. With a passion for translating complex Healthcare concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Healthcare community.